BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21328329)

  • 21. Impact of lymph node ratio and number on survival in patients with rectal adenocarcinoma after preoperative chemo radiation.
    Bhatti ABH; Akbar A; Hafeez A; Syed AA; Khattak S; Jamshed A; Kazmi AS
    Int J Surg; 2015 Jan; 13():65-70. PubMed ID: 25475873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean?
    Habr-Gama A; Perez RO; Proscurshim I; Rawet V; Pereira DD; Sousa AH; Kiss D; Cecconello I
    Dis Colon Rectum; 2008 Mar; 51(3):277-83. PubMed ID: 18183463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
    Rullier A; Laurent C; Capdepont M; Vendrely V; Belleannée G; Bioulac-Sage P; Rullier E
    Am J Surg Pathol; 2008 Jan; 32(1):45-50. PubMed ID: 18162769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer.
    Li Q; Zhuo C; Liang L; Zheng H; Li D; Cai S
    Medicine (Baltimore); 2015 Jan; 94(3):e395. PubMed ID: 25621683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
    Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
    Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up.
    Sprenger T; Rothe H; Homayounfar K; Beissbarth T; Ghadimi BM; Becker H; Liersch T
    J Gastrointest Surg; 2010 Jan; 14(1):96-103. PubMed ID: 19830503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation.
    Kang J; Hur H; Min BS; Lee KY; Kim NK
    J Surg Oncol; 2011 Jul; 104(1):53-8. PubMed ID: 21416471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer.
    Lee WS; Lee SH; Baek JH; Lee WK; Lee JN; Kim NR; Park YH
    Radiat Oncol; 2013 Aug; 8():202. PubMed ID: 23957923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of neoadjuvant therapy on the size, number, and distribution of mesorectal lymph nodes.
    Yegen G; Keskin M; Büyük M; Kunduz E; Balık E; Sağlam EK; Kapran Y; Asoğlu O; Güllüoğlu M
    Ann Diagn Pathol; 2016 Feb; 20():29-35. PubMed ID: 26706785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.
    Scabini S; Montecucco F; Nencioni A; Zoppoli G; Sartini M; Rimini E; Massobrio A; De Marini L; Poggi A; Boaretto R; Romairone E; Ballestrero A; Ferrando V
    World J Surg Oncol; 2013 Nov; 11():292. PubMed ID: 24246069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YpN0 rectal cancer patients with sterilized lymph nodes after neoadjuvant chemoradiotherapy are of greater risk of recurrence.
    Manceau G; Margot N; Augustin J; Bardier A; Simon JM; Bachet JB; Spano JP; Maingon P; Vaillant JC; Karoui M
    Dig Liver Dis; 2020 Feb; 52(2):214-220. PubMed ID: 31427089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of the circumferential extent of tumors and clinical lymph node status as prognostic factors after preoperative chemoradiotherapy and surgery in patients with rectal cancer.
    Yoon WS; Park W; Choi DH; Ahn YC; Chun HK; Lee WY; Yun SH; Kang WK; Lim HY; Park YS
    Tumori; 2010; 96(4):568-76. PubMed ID: 20968136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212).
    Ohue M; Fujita S; Mizusawa J; Kanemitsu Y; Hamaguchi T; Tsukamoto S; Noura S; Yasui M; Itoh M; Shiomi A; Komori K; Watanabe J; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Moriya Y
    Jpn J Clin Oncol; 2022 Feb; 52(2):114-121. PubMed ID: 34865105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node yield after rectal resection is a predictor of survival among patients with node-negative rectal adenocarcinoma.
    Bliggenstorfer JT; Ginesi M; Steinhagen E; Stein SL
    Surgery; 2022 Nov; 172(5):1292-1299. PubMed ID: 35260248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy.
    Luna-Pérez P; Rodríguez-Ramírez S; Alvarado I; Gutiérrez de la Barrera M; Labastida S
    Arch Med Res; 2003; 34(4):281-6. PubMed ID: 12957524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.